Leaflet FEM 7 COMBI transdermal therapeutic system
Indicated for: hormone replacement therapy in menopause
Route of administration: transdermal
Substance: estradiol + levonorgestrel (estrogen and progestogen)
ATC: G03CA53 (Genito urinary system and sex hormones | Estrogens | Natural and semisynthetic estrogens, plain)
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
General data about FEM 7 COMBI
- Substance: estradiol + levonorgestrel
- Date of last drug list: 01-07-2013
- Commercial code: W41892001
- Pharmaceutical form: transdermal therapeutic system
- Quantity: 4
- Product type: original
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.